feed,title,long_url,short_url
MedRxiv,"Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 - January 2023",https://medrxiv.org/cgi/content/short/2023.03.02.23286561v1?rss=1,https://da.gd/4Ysy
MedRxiv,Molnupiravir's real-world effectiveness in COVID-19 non-hospitalized patients at high risk of severe disease: a single-center study,https://medrxiv.org/cgi/content/short/2023.03.03.23286761v1?rss=1,https://da.gd/boZOQ
MedRxiv,Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients,https://medrxiv.org/cgi/content/short/2023.03.01.23286513v1?rss=1,https://da.gd/cAWAS
MedRxiv,Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in the Omicron Era,https://medrxiv.org/cgi/content/short/2023.03.02.23286730v1?rss=1,https://da.gd/XmhY
